Asia Pacific miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Library Preparation, and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)
Market Introduction
miRNA is a small noncoding RNA molecule of 20-30 nucleotides and play an important role in gene regulation. miRNA is partially complementary to messenger RNA (mRNA) and its main function is to downregulate gene expression. Since their discovery they have emerged as vital regulators of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific miRNA sequencing and assay market is expected to reach US$ 104.82 million by 2027 from US$ 40.65 million in 2019; it is estimated to grow at a CAGR of 12.7% from 2020 to 2027. The market growth in this region is mainly attributed to the widening range of microRNA applications and rise in funding for genomics research. However, challenges related to the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.
MicroRNAs (miRNAs) being involved in the process of differentiation, they act as markers in cell type identification. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. Furthermore, new discoveries regarding the role of miRNAs in disease development have made them a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, rise in funding of genomic research to identify new molecules to diagnose and treat diseases, and consequent expansion of the range of applications of miRNAs are driving the growth of the miRNA sequencing and assay market in Asia Pacific.
The COVID-19 pandemic is severely affecting the countries in Asia Pacific. Disruptions in supply chains due to restrictions imposed by various countries on the transportation of goods and humans, along with the enormous demand for effective therapies for the treatment of COVID-19, have put healthcare research industry in critical situation in this region. Further, with the rise in awareness regarding the importance of miRNA sequencing and assay in COVID-19 diagnosis is propelling the demand for miRNA sequencing and assay products. Various international market players are working on the expansion of their businesses in Asia Pacific to leverage significant business potential exhibited by this region. For instance, MiRXES, Singapore, has expanded its business in Asia Pacific by establishing new subsidiary in Japan. Hence, the ongoing pandemic is contributing to the Asia Pacific miRNA sequencing and assay market growth.
Key Market Segments
The Asia Pacific miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on technology, the Asia Pacific miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.
Based on end user, the Asia Pacific miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the Asia Pacific miRNA sequencing and assay market are the Organization for Economic Cooperation and Development (OECD), Institute for Research in Genetic Engineering and Molecular Biology (INGBEI) and Commonwealth Scientific and Industrial Research Organization (CSIRO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis Asia Pacific miRNA sequencing and assay market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacific miRNA sequencing and assay market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within Asia Pacific miRNA sequencing and assay market.
Asia Pacific MiRNA Sequencing and Assay Market Segmentation
By Product
- Library Preparation
- Consumables
By Technology
- Sequencing by Synthesis
- Nanopore
- Ion Semiconductor Sequencing
By End User
- Research Institute
- Academia
- CRO
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific miRNA Sequencing and Assay Market – By Product
1.3.2 Asia Pacific miRNA Sequencing and Assay Market – By Technology
1.3.3 Asia Pacific miRNA Sequencing and Assay Market – By End User
1.3.4 Asia Pacific miRNA Sequencing and Assay market – By Country
2. miRNA Sequencing and Assay Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific miRNA Sequencing and Assay – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. miRNA Sequencing and Assay Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Widening Range of MicroRNA Applications
5.1.2 Rise in Funding for Genomics Research
5.2 Market Restraints
5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics
5.3 Market Opportunities
5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis
6. miRNA Sequencing and Assay Market – Asia Pacific Analysis
6.1 Asia Pacific miRNA Sequencing and Assay Market Revenue Forecast and Analysis
7. miRNA Sequencing and Assay Market Analysis – By Product
7.1 Overview
7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
7.3 Library Preparation
7.3.1 Overview
7.3.2 Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8. miRNA Sequencing and Assay Market Analysis – By Technology
8.1 Overview
8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)
8.3 Sequencing By Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Nanopore
8.4.1 Overview
8.4.2 Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Ion Semiconductor Sequencing
8.5.1 Overview
8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9. miRNA Sequencing and Assay Market Analysis – By End User
9.1 Overview
9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)
9.3 Research Institute
9.3.1 Overview
9.3.2 Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Academia
9.4.1 Overview
9.4.2 Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
10. miRNA Sequencing and Assay Market – Asia Pacific Analysis
10.1 Asia Pacific: miRNA Sequencing and Assay Market
10.1.1 Overview
10.1.2 Asia Pacific: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
10.1.3 China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 China: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.3.3 China: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.3.4 China miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.4 Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 Japan: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.4.3 Japan: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.4.4 Japan miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.5 India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 India: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.5.3 India: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.5.4 India miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.6 South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 South Korea: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.6.3 South Korea: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.6.4 South Korea miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.7 Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Australia: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.7.3 Australia: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.7.4 Australia miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
10.1.8 Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Asia Pacific: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Rest of Asia Pacific: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)
10.1.8.4 Rest of Asia Pacific miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific miRNA Sequencing and Assay Market
11.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Takara Bio Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 New England Biolabs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Norgen Biotek Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lexogen GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. China miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 3. China miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Japan miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. India miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. India miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. India miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. South Korea miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 15. Australia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Asia Pacific miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Asia Pacific miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of Asia Pacific miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, miRNA Sequencing and Assay Market
LIST OF FIGURES
Figure 1. miRNA Sequencing and Assay Market Segmentation
Figure 2. miRNA Sequencing and Assay Market Segmentation, By Country
Figure 3. Asia Pacific miRNA Sequencing and Assay Market Overview
Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth
Figure 5. Asia Pacific miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
Figure 10. Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)
Figure 13. Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)
Figure 17. Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Asia Pacific: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. Asia Pacific: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
Figure 22. China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific miRNA sequencing and assay market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific miRNA sequencing and assay market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.